chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Myalgia, Pain, Pyrexia
Clinical narrative: pain above left clavicle; Lymph nodes in neck are severely swollen, golf ball size; body aches; fever; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), PYREXIA (fever), FATIGUE (exhaustion), PAIN (pain above left clavicle) and LYMPHADENOPATHY (Lymph nodes in neck are severely swollen, golf ball size) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced MYALGIA (body aches), PYREXIA (fever) and FATIGUE (exhaustion). On 24-Mar-2021, the patient experienced PAIN (pain above left clavicle) and LYMPHADENOPATHY (Lymph nodes in neck are severely swollen, golf ball size). At the time of the report, MYALGIA (body aches), PYREXIA (fever), FATIGUE (exhaustion), PAIN (pain above left clavicle) and LYMPHADENOPATHY (Lymph nodes in neck are severely swollen, golf ball size) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs included no treatment included
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not reported.  29 and 9 weeks pregnant now. She received the first shot when she was around 4 or 5 weeks and got the second shot yesterday (March 16th).  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: received no new information.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: A little Sore Injection Site Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little Sore Injection Site Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (A little Sore Injection Site Pain). On 10-Mar-2021, VACCINATION SITE PAIN (A little Sore Injection Site Pain) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Tenderness, Type IV hypersensitivity reaction, Vaccination site induration, Vaccination site pruritus
Clinical narrative: "Moderna arm"; redness; warm injection site; tenderness and hardness on injection site; tenderness and hardness on injection site; itching on injection site; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION ("Moderna arm"), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm injection site), TENDERNESS (tenderness and hardness on injection site) and VACCINATION SITE INDURATION (tenderness and hardness on injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included vitamins D and C, multivitamins with Ca+Mg and PROBIOTICS NOS for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION ("Moderna arm"), ERYTHEMA (redness),VACCINATION SITE WARMTH (warm injection site), TENDERNESS (tenderness and hardness on injection site) and VACCINATION SITE PRURITUS (itching on injection site). On an unknown date, the patient experienced VACCINATION SITE INDURATION (tenderness and hardness on injection site). On 16-Mar-2021, TYPE IV HYPERSENSITIVITY REACTION ("Moderna arm"), ERYTHEMA (redness), INJECTION SITE WARMTH (warm injection site), TENDERNESS (tenderness and hardness on injection site) and VACCINATION SITE PRURITUS (itching on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: "Moderna arm"; redness; warm injection site; tenderness and hardness on injection site; tenderness and hardness on injection site; itching on injection site; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION ("Moderna arm"), ERYTHEMA (redness), VACCINATION SITE WARMTH (warm injection site), TENDERNESS (tenderness and hardness on injection site) and VACCINATION SITE INDURATION (tenderness and hardness on injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included vitamins D and C, multivitamins with Ca+Mg and PROBIOTICS NOS for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION ("Moderna arm"), ERYTHEMA (redness),VACCINATION SITE WARMTH (warm injection site), TENDERNESS (tenderness and hardness on injection site) and VACCINATION SITE PRURITUS (itching on injection site). On an unknown date, the patient experienced VACCINATION SITE INDURATION (tenderness and hardness on injection site). On 16-Mar-2021, TYPE IV HYPERSENSITIVITY REACTION ("Moderna arm"), ERYTHEMA (redness), INJECTION SITE WARMTH (warm injection site), TENDERNESS (tenderness and hardness on injection site) and VACCINATION SITE PRURITUS (itching on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Muscle spasms, Paraesthesia, Vaccination site pain
Clinical narrative: no strength in injection arm; very sore injection arm; tingling from injection to finger tips; cramping in injection arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (no strength in injection arm), VACCINATION SITE PAIN (very sore injection arm), PARAESTHESIA (tingling from injection to finger tips) and MUSCLE SPASMS (cramping in injection arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced ASTHENIA (no strength in injection arm), VACCINATION SITE PAIN (very sore injection arm), PARAESTHESIA (tingling from injection to finger tips) and MUSCLE SPASMS (cramping in injection arm). At the time of the report, ASTHENIA (no strength in injection arm), VACCINATION SITE PAIN (very sore injection arm), PARAESTHESIA (tingling from injection to finger tips) and MUSCLE SPASMS (cramping in injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs included no treatment drugs included
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort
Clinical narrative: feeling of the throat slightly closing up; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (feeling of the throat slightly closing up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Brain tumor. Concomitant products included BENAZEPRIL;HYDROCHLOROTHIAZIDE, AMLODIPINE BENZOATE, AMITRIPTYLINE HCL, CLORAZEPATE DIPOTASSIUM (CLORAZEPATE), MULTIVITAMINS [VITAMINS NOS] and CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (feeling of the throat slightly closing up). At the time of the report, OROPHARYNGEAL DISCOMFORT (feeling of the throat slightly closing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment details were provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dizziness, Muscular weakness, Tachycardia
Clinical narrative: Coughing; She was dizzy; She experienced a rapid heart beat; She experienced weakness of both legs; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (She experienced weakness of both legs), COUGH (Coughing), DIZZINESS (She was dizzy) and TACHYCARDIA (She experienced a rapid heart beat) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MUSCULAR WEAKNESS (She experienced weakness of both legs). On 05-Mar-2021, the patient experienced COUGH (Coughing), DIZZINESS (She was dizzy) and TACHYCARDIA (She experienced a rapid heart beat). At the time of the report, MUSCULAR WEAKNESS (She experienced weakness of both legs), COUGH (Coughing), DIZZINESS (She was dizzy) and TACHYCARDIA (She experienced a rapid heart beat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Headache, Myalgia, Neck pain
Clinical narrative: headache; neckache; diarrhea; low grade fever; muscle pain; Joint pain; bump on injection site 6inches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NECK PAIN (neckache), DIARRHOEA (diarrhea), PYREXIA (low grade fever) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (headache), NECK PAIN (neckache), DIARRHOEA (diarrhea), PYREXIA (low grade fever), MYALGIA (muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE NODULE (bump on injection site 6inches). At the time of the report, HEADACHE (headache), NECK PAIN (neckache), DIARRHOEA (diarrhea), PYREXIA (low grade fever), MYALGIA (muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE NODULE (bump on injection site 6inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs included No treatment drugs included
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site nodule
Clinical narrative: headache; neckache; diarrhea; low grade fever; muscle pain; Joint pain; bump on injection site 6inches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NECK PAIN (neckache), DIARRHOEA (diarrhea), PYREXIA (low grade fever) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (headache), NECK PAIN (neckache), DIARRHOEA (diarrhea), PYREXIA (low grade fever), MYALGIA (muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE NODULE (bump on injection site 6inches). At the time of the report, HEADACHE (headache), NECK PAIN (neckache), DIARRHOEA (diarrhea), PYREXIA (low grade fever), MYALGIA (muscle pain), ARTHRALGIA (Joint pain) and VACCINATION SITE NODULE (bump on injection site 6inches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs included No treatment drugs included
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20 and 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided. patient said his arm was only slightly sore and went away in a day or so. He is feeling fine now. No further FU needed.   This case was linked to MOD-2021-060547, MOD-2021-061044 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: patient is feeling fine now.No further FU needed.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site reaction, Pruritus, Rash, Sensation of foreign body
Clinical narrative: Throat tightness; I had to keep clearing my throat to make my self comfortable; Itchy; Covid arm; Diffuse rashes over arm; Red; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Throat tightness), SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable), PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm) and RASH (Diffuse rashes over arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced THROAT TIGHTNESS (Throat tightness), SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable), PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm), RASH (Diffuse rashes over arm) and INJECTION SITE ERYTHEMA (Red). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of Unknown and DIPHENHYDRAMINE at a dose of Unknown. On 20-Feb-2021, PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm), RASH (Diffuse rashes over arm) and INJECTION SITE ERYTHEMA (Red) had resolved. On 16-Mar-2021, THROAT TIGHTNESS (Throat tightness) and SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Medical history and Concomitants were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Follow-up received on 29-03-2021 updated events and anatomy location . Events are red, delayed reaction, at the same time had throat tightness. On 05-Aug-2021: Follow up received contains No New Information. On 05-Aug-2021: Follow up received contains No New Information
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: Throat tightness; I had to keep clearing my throat to make my self comfortable; Itchy; Covid arm; Diffuse rashes over arm; Red; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Throat tightness), SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable), PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm) and RASH (Diffuse rashes over arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced THROAT TIGHTNESS (Throat tightness), SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable), PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm), RASH (Diffuse rashes over arm) and INJECTION SITE ERYTHEMA (Red). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of Unknown and DIPHENHYDRAMINE at a dose of Unknown. On 20-Feb-2021, PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm), RASH (Diffuse rashes over arm) and INJECTION SITE ERYTHEMA (Red) had resolved. On 16-Mar-2021, THROAT TIGHTNESS (Throat tightness) and SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Medical history and Concomitants were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Follow-up received on 29-03-2021 updated events and anatomy location . Events are red, delayed reaction, at the same time had throat tightness. On 05-Aug-2021: Follow up received contains No New Information. On 05-Aug-2021: Follow up received contains No New Information
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Breast tenderness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of breast tenderness (some tenderness on left breast) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 004M20A) for COVID-19 vaccination. The patient's past medical history included no adverse event. On Feb 10, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced  breast tenderness (some tenderness on left breast). At the time of the report,  breast tenderness (some tenderness on left breast) outcome: unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Vaccination site erythema, Vaccination site pain
Clinical narrative: arm was sore and red; sore arm; blister; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLISTER (blister), VACCINATION SITE ERYTHEMA (arm was sore and red) and VACCINATION SITE PAIN (sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced BLISTER (blister). On 28-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm was sore and red) and VACCINATION SITE PAIN (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BLISTER (blister), VACCINATION SITE ERYTHEMA (arm was sore and red) and VACCINATION SITE PAIN (sore arm) outcome was unknown.            No relevant concomitant medications were reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy
Clinical narrative: Fatigue; Feeling Lathargic; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and LETHARGY (Feeling Lathargic) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (Fatigue) and LETHARGY (Feeling Lathargic). At the time of the report, FATIGUE (Fatigue) and LETHARGY (Feeling Lathargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs included No treatment drugs included
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash macular, Vaccination site erythema
Clinical narrative: underneath her breast a big red spot like an iron burn but not itchy; red spot at injection site; pain arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain arm), RASH MACULAR (underneath her breast a big red spot like an iron burn but not itchy) and VACCINATION SITE ERYTHEMA (red spot at injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain arm) and VACCINATION SITE ERYTHEMA (red spot at injection site). On 28-Mar-2021, the patient experienced RASH MACULAR (underneath her breast a big red spot like an iron burn but not itchy). At the time of the report, PAIN IN EXTREMITY (pain arm), RASH MACULAR (underneath her breast a big red spot like an iron burn but not itchy) and VACCINATION SITE ERYTHEMA (red spot at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included hydrocortisone cream, Benadryl no concomitant drugs included
Sex: U
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Injection site warmth, Pyrexia
Clinical narrative: high fever - 103.7 F; body chills; area around the injection site warm to touch; diarrhea on the same evening of her shot for 3-4 hrs; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever - 103.7 F), CHILLS (body chills), INJECTION SITE WARMTH (area around the injection site warm to touch) and DIARRHOEA (diarrhea on the same evening of her shot for 3-4 hrs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00ZAZ1A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (high fever - 103.7 F), CHILLS (body chills), INJECTION SITE WARMTH (area around the injection site warm to touch) and DIARRHOEA (diarrhea on the same evening of her shot for 3-4 hrs). At the time of the report, PYREXIA (high fever - 103.7 F), CHILLS (body chills), INJECTION SITE WARMTH (area around the injection site warm to touch) and DIARRHOEA (diarrhea on the same evening of her shot for 3-4 hrs) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: Asthma attack; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHMA (Asthma attack) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHMA (Asthma attack). At the time of the report, ASTHMA (Asthma attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Prednisone was administered as treatment for the event. At the time of the report the patient was on day 4 of 5 of the treatment cycle.  No concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: Feeling very sleepy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Feeling very sleepy) and FATIGUE (Tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced SOMNOLENCE (Feeling very sleepy) and FATIGUE (Tired). On 25-Mar-2021, SOMNOLENCE (Feeling very sleepy) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Fatigue, Pyrexia
Clinical narrative: Could not keep anything down; Chills; Tired; Fevers; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Could not keep anything down), CHILLS (Chills), FATIGUE (Tired) and PYREXIA (Fevers) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A. and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced DISCOMFORT (Could not keep anything down), CHILLS (Chills), FATIGUE (Tired) and PYREXIA (Fevers). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DISCOMFORT (Could not keep anything down), CHILLS (Chills), FATIGUE (Tired) and PYREXIA (Fevers) outcome was unknown.            Concomitants were not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Eye movement disorder
Clinical narrative: Eye was quivering and trembling for a short while; This spontaneous case was reported by a consumer and describes the occurrence of EYE MOVEMENT DISORDER (Eye was quivering and trembling for a short while) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 040A01A) for COVID-19 vaccination.     Concomitant products included VITAMIN B COMPLEX (B-COMPLEX [VITAMIN B COMPLEX]) and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced EYE MOVEMENT DISORDER (Eye was quivering and trembling for a short while). At the time of the report, EYE MOVEMENT DISORDER (Eye was quivering and trembling for a short while) had resolved.            Concomitant product included Hair ,Skin, Nails vitamins. The patient treatment data was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-060473 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: updated the event outcome from unknown to recovered/ resolved On 27-May-2021: Reporter said she did not have an email ID or fax number and said she felt better.; Sender's Comments:  -MODERNATX, INC.-MOD-2021-060473:2nd dose
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart Palpitation; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitation) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had COVID-19 prior to the vaccine). Concurrent medical conditions included Muscle pain (Still experiencing the muscle pain even after having COVID).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PALPITATIONS (Heart Palpitation). The patient was treated with DIAZEPAM (VALIUM) at a dose of 4 mg; OLMESARTAN MEDOXOMIL (BENICAR) at a dose of 20 mg and METOPROLOL SUCCINATE (TOPROL) at a dose of 25 mg. At the time of the report, PALPITATIONS (Heart Palpitation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant medication history included Blood pressure medications. No relevant concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Significant follow up added.Reporters contact information updated, Patients Historical condition and current condition added
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Myalgia, Nightmare
Clinical narrative: Legs hurting; Night mares; Swelling of neck lymph nodes; Muscle aches; Fatigue is not going away / Exhausted despite sleeping; Bad Headache; Soreness at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 29-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs hurting), NIGHTMARE (Night mares), VACCINATION SITE PAIN (Soreness at the injection site), HEADACHE (Bad Headache) and LYMPHADENOPATHY (Swelling of neck lymph nodes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 21-Mar-2021, the patient experienced HEADACHE (Bad Headache). On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (Legs hurting), NIGHTMARE (Night mares), LYMPHADENOPATHY (Swelling of neck lymph nodes), MYALGIA (Muscle aches) and FATIGUE (Fatigue is not going away / Exhausted despite sleeping). At the time of the report, PAIN IN EXTREMITY (Legs hurting), NIGHTMARE (Night mares), VACCINATION SITE PAIN (Soreness at the injection site), HEADACHE (Bad Headache), LYMPHADENOPATHY (Swelling of neck lymph nodes), MYALGIA (Muscle aches) and FATIGUE (Fatigue is not going away / Exhausted despite sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Legs hurting; Night mares; Swelling of neck lymph nodes; Muscle aches; Fatigue is not going away / Exhausted despite sleeping; Bad Headache; Soreness at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 29-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs hurting), NIGHTMARE (Night mares), VACCINATION SITE PAIN (Soreness at the injection site), HEADACHE (Bad Headache) and LYMPHADENOPATHY (Swelling of neck lymph nodes) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 21-Mar-2021, the patient experienced HEADACHE (Bad Headache). On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (Legs hurting), NIGHTMARE (Night mares), LYMPHADENOPATHY (Swelling of neck lymph nodes), MYALGIA (Muscle aches) and FATIGUE (Fatigue is not going away / Exhausted despite sleeping). At the time of the report, PAIN IN EXTREMITY (Legs hurting), NIGHTMARE (Night mares), VACCINATION SITE PAIN (Soreness at the injection site), HEADACHE (Bad Headache), LYMPHADENOPATHY (Swelling of neck lymph nodes), MYALGIA (Muscle aches) and FATIGUE (Fatigue is not going away / Exhausted despite sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Chills, Cough, Pain in extremity, Productive cough
Clinical narrative: Productive cough; Feeling "bubbling up"; Cough; Arm was very sore; Injection site was itchy; Injection site was swollen; Injection site had red dot line; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Productive cough), ABDOMINAL DISTENSION (Feeling "bubbling up"), COUGH (Cough), PAIN IN EXTREMITY (Arm was very sore) and VACCINATION SITE PRURITUS (Injection site was itchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROPRANOLOL HYDROCHLORIDE (INDERAL) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCTIVE COUGH (Productive cough), ABDOMINAL DISTENSION (Feeling "bubbling up"), COUGH (Cough), PAIN IN EXTREMITY (Arm was very sore), VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE ERYTHEMA (Injection site had red dot line) and CHILLS (Chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PRODUCTIVE COUGH (Productive cough), ABDOMINAL DISTENSION (Feeling "bubbling up"), COUGH (Cough), PAIN IN EXTREMITY (Arm was very sore), VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE ERYTHEMA (Injection site had red dot line) and CHILLS (Chills) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-060530 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Productive cough; Feeling "bubbling up"; Cough; Arm was very sore; Injection site was itchy; Injection site was swollen; Injection site had red dot line; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Productive cough), ABDOMINAL DISTENSION (Feeling "bubbling up"), COUGH (Cough), PAIN IN EXTREMITY (Arm was very sore) and VACCINATION SITE PRURITUS (Injection site was itchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROPRANOLOL HYDROCHLORIDE (INDERAL) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCTIVE COUGH (Productive cough), ABDOMINAL DISTENSION (Feeling "bubbling up"), COUGH (Cough), PAIN IN EXTREMITY (Arm was very sore), VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE ERYTHEMA (Injection site had red dot line) and CHILLS (Chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PRODUCTIVE COUGH (Productive cough), ABDOMINAL DISTENSION (Feeling "bubbling up"), COUGH (Cough), PAIN IN EXTREMITY (Arm was very sore), VACCINATION SITE PRURITUS (Injection site was itchy), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE ERYTHEMA (Injection site had red dot line) and CHILLS (Chills) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-060530 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Headache, Infusion site warmth, Myalgia
Clinical narrative: Warm body; Bone pain; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of INFUSION SITE WARMTH (Warm body), BONE PAIN (Bone pain), HEADACHE (Headache) and MYALGIA (Body aches) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 01102QA) for COVID-19 vaccination.     Concomitant products included LOSARTAN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), GLIPIZIDE, SIMVASTATIN, ALENDRONATE SODIUM (ALENDRONATE) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced INFUSION SITE WARMTH (Warm body), BONE PAIN (Bone pain), HEADACHE (Headache) and MYALGIA (Body aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency and OSELTAMIVIR at an unspecified dose and frequency. At the time of the report, INFUSION SITE WARMTH (Warm body), BONE PAIN (Bone pain), HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Pain in Back between shoulder blades; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Pain in Back between shoulder blades) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced BACK PAIN (Pain in Back between shoulder blades). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Pain in Back between shoulder blades) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Maternal exposure during breast feeding, Pain in extremity
Clinical narrative: Breast feeding; Sore arm; Headache; Tired; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Breast feeding), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breast feeding), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tired). On 12-Mar-2021, PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tired) had resolved. At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (Breast feeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.   The patient stated that she was currently breastfeeding a 5 month old baby boy.   Treatment information was not reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling
Clinical narrative: Swollen arm; A little redness; A little pain; This spontaneous case was reported by an other health care professional and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (A little redness) and PAIN (A little pain) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Open heart surgery (For a valve replacement). Concurrent medical conditions included Shortness of breath.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (A little redness) and PAIN (A little pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 29-Jan-2021, PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (A little redness) and PAIN (A little pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.   This case was linked to MOD-2021-060529 (Patient Link).
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Swollen left arm; He couldn't even move his left arm; Fever of 99 to 100; Headache; Chills; Muscle ache; Joint pain; A lot of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen left arm), VACCINATION SITE MOVEMENT IMPAIRMENT (He couldn't even move his left arm), PYREXIA (Fever of 99 to 100), HEADACHE (Headache) and CHILLS (Chills) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen left arm), VACCINATION SITE MOVEMENT IMPAIRMENT (He couldn't even move his left arm), PYREXIA (Fever of 99 to 100), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain) and FATIGUE (A lot of fatigue). The patient was treated with IBUPROFEN on 28-Mar-2021 at an unspecified dose and frequency. On 29-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen left arm), VACCINATION SITE MOVEMENT IMPAIRMENT (He couldn't even move his left arm), PYREXIA (Fever of 99 to 100), CHILLS (Chills), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain) and FATIGUE (A lot of fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Body temperature: 99 to 100 (High) 99 to 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site movement impairment, Vaccination site swelling
Clinical narrative: Swollen left arm; He couldn't even move his left arm; Fever of 99 to 100; Headache; Chills; Muscle ache; Joint pain; A lot of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen left arm), VACCINATION SITE MOVEMENT IMPAIRMENT (He couldn't even move his left arm), PYREXIA (Fever of 99 to 100), HEADACHE (Headache) and CHILLS (Chills) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen left arm), VACCINATION SITE MOVEMENT IMPAIRMENT (He couldn't even move his left arm), PYREXIA (Fever of 99 to 100), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain) and FATIGUE (A lot of fatigue). The patient was treated with IBUPROFEN on 28-Mar-2021 at an unspecified dose and frequency. On 29-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen left arm), VACCINATION SITE MOVEMENT IMPAIRMENT (He couldn't even move his left arm), PYREXIA (Fever of 99 to 100), CHILLS (Chills), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain) and FATIGUE (A lot of fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Body temperature: 99 to 100 (High) 99 to 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.